Applied Molecular Evolution to Present at CIBC World Markets Healthcare Conference November 10
06 Noviembre 2003 - 10:14AM
PR Newswire (US)
Applied Molecular Evolution to Present at CIBC World Markets
Healthcare Conference November 10 SAN DIEGO, Nov. 6
/PRNewswire-FirstCall/ -- Applied Molecular Evolution, Inc. (AME)
announced today that Dr. Lawrence E. Bloch, Chief Financial Officer
of AME, will present an overview of the Company at the Fourteenth
Annual CIBC World Markets Healthcare Conference on Monday, November
10, 2003 at 8:30 am ET. The presentation will be webcast live and
will be available via archive approximately three hours following
the presentation at http://www.ame.biz/ . About Applied Molecular
Evolution Applied Molecular Evolution, Inc. (AME) is a leader in
applying directed molecular evolution to improve healthcare by
optimizing and developing human biotherapeutics. Directed molecular
evolution is a process for optimizing genes and proteins for
specific commercial purposes. Since its inception, AME's principal
focus has been on applying its proprietary AMEsystem(TM) technology
platform to human biotherapeutics, the largest market for directed
molecular evolution. Biotherapeutics, or biopharmaceuticals, are
protein pharmaceuticals such as antibodies, cytokines, hormones and
enzymes. AME uses its proprietary technology to develop improved
versions of currently marketed, FDA-approved biopharmaceuticals as
well as novel human biotherapeutics. For more information, please
visit http://www.ame.biz/ . This press release contains
forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially
from those set forth in the forward-looking statements, including
uncertainties related to product development, uncertainties related
to the need for regulatory or other government approvals,
dependence on proprietary technology, uncertainty of market
acceptance of the Company's products, uncertainties related to
business opportunities, the receipt of future payments, including
royalties, the continuation of customer relationships and other
risks cited in the Company's Annual Report on Form 10-K for the
year ended December 31, 2002, and other SEC Filings. These
forward-looking statements speak only as of the date hereof. The
Company disclaims any intent or obligation to update these
forward-looking statements. For further information, please
contact, Chris Erdman of Applied Molecular Evolution,
+1-858-638-8635. DATASOURCE: Applied Molecular Evolution CONTACT:
Chris Erdman of Applied Molecular Evolution, +1-858-638-8635 Web
site: http://www.ame.biz/
Copyright
Applied Molecular Evolution (NASDAQ:AMEV)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Applied Molecular Evolution (NASDAQ:AMEV)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Applied Molecular Evolution, (MM) (NASDAQ): 0 recent articles
Más de Applied Molecular Evolution, (MM) Artículos de Noticias